The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.

The 2023 to 2024 COVID-19 vaccine provided additional effectiveness against medically attended COVID-19, according to a study published online June 24 in JAMA Network Open. Ruth Link-Gelles, Ph.D., M.

FDA vaccines chief Vinay Prasad limited broader use of COVID vaccines, citing reduced risk and data concerns. Read more here.

In a comprehensive Genomic Press Innovators & Ideas interview, Dr. Danielle Beckman reveals how her passion for microscopy ...

The Hawaii volcano erupted again on Sunday (June 29) for the 27th time since December 2024. South Africa petrol prices: ...

The University of Minnesota is stepping up efforts to identify biological threats that could trigger an epidemic, launching ...

Rapid diagnostics continue transforming healthcare delivery worldwide, fueled by aging populations, decentralized care models, technological converge ...

Sharp throat pain that feels like swallowing razor blades—this symptom is particularly noticeable in infections with the new ...

In patients with COVID-19, preexisting immunity and Omicron infection were associated with reduced disease severity and upper respiratory symptom presentation.

Sea moss (Chondrus crispus) is a red macroalga lauded for its rich mineral content, prebiotic fibers, and potential health ...

The Indian Council of Medical Research (ICMR) and the National Institute of Epidemiology have conducted several studies in States and Union territories. India continues to carry a substantial burden, ...

The firm is seeking marketing clearance for its Liaison NES real-time PCR instrument along with a multiplex test for flu A/B, COVID-19, and respiratory syncytial virus infection.